As an alternative suggestion to explain our data, EGCG has been shown to inhibit DOPA decarboxylase, slowing conversion of l-DOPA into dopamine; the upstream product of NA and AD within adrenal medulla chromaffin cells and sympathetic neuron [48]. The gene discussed is DDC; the disease is Alzheimer disease.